赛升药业 (300485)
Beijing Science Sun Pharmaceutical Co.,LTD.
K-Line Chart
No K-line data available
Company NameBeijing Saisheng Pharmaceutical Co., Ltd.
Listing Date2015-06-26
Issue Price38.46RMB
Registered Capital48166.6410k RMB
Legal RepresentativeMa Biao
Registered AddressNo. 8 Xingsheng Street, Beijing Economic-Technological Development Area, Beijing
IndustryBiological Products
Main BusinessResearch, development, production, and sales of biochemical and biological drugs
Company ProfileBeijing Saisheng Pharmaceutical Co., Ltd. was established on July 28, 2011, through the overall restructuring of Beijing Saisheng Pharmaceutical Co., Ltd. It is currently located at No. 8 Xingsheng Street, Beijing Economic-Technological Development Area, with a registered capital of 240 million yuan. Founded in 1999, Saisheng Pharmaceutical is a high-tech enterprise specializing in the research, development, production, and sales of biological drugs (active proteases, active polypeptides, active polysaccharides, amphoteric lipids). The company has one holding subsidiary and one marketing center. Its product sales network covers the whole country, and the safety and effectiveness of its products have been widely recognized by the market.
Stock Details
1. Key Indicators
- Total Shares(W): 48166.64
- Circulating A-Shares(W): 27381.72
- Earnings Per Share(RMB): 0.1100
- Net Assets Per Share(RMB): 7.0766
- Operating Revenue(W RMB): 30862.71
- Total Profit(W RMB): 5919.54
- Net Profit Attributable to Parent(W RMB): 5185.96
- Net Profit Growth Rate(%): 152.81
- Weighted Return on Equity(%): 1.5300
- Operating Cash Flow Per Share(RMB): 0.0630
- Undistributed Profit Per Share(RMB): 3.8102
- Capital Reserve Per Share(RMB): 1.7563
2. Main Business
The main business covers:
- Research, production and sales of injection preparations
3. Company Basic Information
- Company Name: Beijing Science Sun Pharmaceutical Co., Ltd.
- Listing Date: 2015-06-26
- Industry: Pharmaceutical Manufacturing
- Address: No. 8 Xingsheng Street, Beijing Economic-Technological Development Area, Beijing, China
- Website: www.ssyy.com.cn
- Company Profile: On July 21, 1998, the Beijing Pharmaceutical Administration issued document ([98] Jing Yi Yao Ju Gui Bu Zi No. 019) approving the establishment of Saisheng Pharmaceutical by the Biochemical Factory, Shenyang Sainuo, and the Pharmaceutical Group. On June 28, 2011, a resolution was passed at the shareholders' meeting of Saisheng Pharmaceutical, with all shareholders agreeing to act as promoters to transform the company into a joint stock limited company and rename it as Beijing Science Sun Pharmaceutical Co., Ltd. On July 28, 2011, the issuer completed the change of registration with the Beijing Administration for Industry and Commerce and obtained the business license with registration number 110302000409597.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | UBS AG | QFII | 174.99 | 0.64 |
| 2 | CITIC Securities Asset Management (Hong Kong) Limited - Client Funds | Asset Management Plan | 148.38 | 0.54 |
| 3 | J. P. Morgan Securities PLC - Proprietary Funds | QFII | 138.06 | 0.50 |
| 4 | Goldman Sachs & Co. LLC | QFII | 95.80 | 0.35 |
5. Concept Sectors
- Venture Capital Concept
- Biological Vaccine
- Assisted Reproduction
- Hepatitis Concept
- Innovative Drug
- Non-Recurring Loss
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information